Inhibitors of retroviral protease

Patent 5342922 Issued on August 30, 1994. Estimated Expiration Date:

August 30, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Inventors

Application

No. 320742 filed on 03/08/1989

US Classes:

530/3296 to 7 amino acid residues in defined sequence

Examiners

Primary: Cashion, Merrell C. Jr.
Assistant: Marshall, S. G.

Attorney, Agent or Firm

Meyer; Scott J.

Foreign Patent References

301570 EP 02/13/1989

International Classes

C07K 007/06
A61K 037/02

Abstract

Novel inhibitors of retroviral protease, e.g., HIV protease, are provided which are peptides having from about 4 to about 8 amino acid residues and which are substrates for said protease derived from known cleavage sites and modified to contain an internal CH2 NH bond isostere.

Other References

Schneider, et al. Cell, vol. 54, pp. 363-368, 1988
Rich, "Inhibitors of aspartic proteinases," Barrett and Salvesen, eds., Elsevier Sci Publ. 1987, pp. 179-287
Pearl, et al, "Sequence specificify of retroviral protease", Nature 326, 482 (1987)
Billich et al, "Synthetic Peptides as Substrates and Inhibitors of Human Immune Deficiency Virus--I Protease," J. Biol. Chem. 263, 17905-17908, 1988
Korant et al., J. Cell. Biochem. 32, 91-95 (1986)
Katoh et al., Nature 329, 654-656 (1987)
Krausslick et al., J. Virology 62, 4393-4397 (1988)
Nutt et al., Proc. Natl. Acad. Sci. USA 85, 7179-7233(1988)
Seelmeier et al., Proc. Natl. Acad. Sci. USA 85, 6612-6616 (1985)
Kohl et al., Proc. Natl. Acad. Sci. USA 85, 4686-4690 (1988)
Darke et al., Biochem. Biophys. Res. Commun. 156, 297-303 (1988)
Kotler et al., Proc. Natl. Acad. Sci. USA 85, 4185-4189 (1988)
Sasaki et al., J. Med. Chem. 30, 1162-1166 (1987)
Toh et al., Nature 315, 691 (1985